The U.S. Army has signed a new implementation plan acknowledging that it is impossible to shield every soldier from every potential biological threat. Dr. Alison Tamasi, a senior official at the Army's Nuclear and Countering Weapons of Mass Destruction Agency, stated that while complete protection is unattainable, the force must be prepared to operate through biological attacks. The strategy, finalized last week, integrates biological warfare scenarios into routine combat training to ensure troops can deploy and fight in biologically contested environments by 2035.
The shift in doctrine comes amid rising concerns that artificial intelligence and biotechnology are accelerating the development of new biological threats. While the Army previously treated outbreaks primarily as medical emergencies, the new approach requires commanders, intelligence officers, and logistics personnel to manage biological disruptions as part of their core combat missions. This change reflects a broader assessment by U.S. officials regarding the transparency of foreign biological programs, particularly in Russia.
What the Left Is Saying
Progressive critics and national security analysts have long argued that the United States must adhere strictly to international non-proliferation treaties while preparing for the dual-use nature of modern biotechnology. They emphasize that the Biological Weapons Convention, which the U.S. joined in 1975 after renouncing offensive programs in 1969, requires robust transparency measures. Critics note that the integration of AI into biotech research presents ethical and security challenges that require international cooperation rather than solely military adaptation. They argue that the Army’s focus on operational resilience should not distract from diplomatic efforts to verify compliance among signatory nations.
What the Right Is Saying
Conservative commentators and national security hawks view the Army’s new plan as a necessary and overdue adjustment to a deteriorating global security landscape. They point to the mysterious death of Darya Shipilova at the Irkutsk Anti-Plague Research Institute in Russia as evidence that state-sponsored biological risks remain significant despite official denials. Proponents of the strategy argue that assuming adversaries maintain offensive biological capabilities, as the U.S. has assessed regarding Moscow’s Soviet-inherited program, is prudent. They contend that treating biological threats as operational disruptions, rather than just medical issues, is essential for maintaining military superiority against potential state and non-state actors.
What the Numbers Show
The Army’s updated biodefense strategy, released in September and implemented last week, sets a 2035 deadline for full readiness in biologically contested environments. The first two-year implementation cycle focuses on establishing policies and developing specialized personnel, with advanced technology acquisition scheduled for later phases. Dr. Tamasi described scenarios such as a simulated norovirus outbreak at a military port, where logistics officers must maintain supply chains while medical teams contain the spread. The plan moves away from specialized biological exercises to embedding these threats into major Army combat exercises. Additionally, the World Health Organization reported on Oct. 10 that it found no evidence of ongoing transmission linked to the Russian laboratory incident, though a confirmed diagnosis for Shipilova’s death remains undetermined.
The Bottom Line
The Army’s admission that soldiers cannot be placed in a protective bubble marks a significant doctrinal shift from prevention to resilience. By integrating biological threats into standard combat training, the military aims to ensure that logistics and command structures remain functional during outbreaks. This approach acknowledges the dual-use challenge posed by AI and biotechnology, which can accelerate both medical discoveries and the development of new threats. The strategy’s success will depend on the effective coordination of specialized personnel and the alignment of doctrine across all Army organizations. Future phases will focus on acquiring advanced technologies to mitigate these risks, while ongoing international assessments of foreign biological programs will continue to inform U.S. preparedness efforts.